Evidence map›Paper›PMID 26223634›Full record

ArticleJournal of virology2015

Fitness-Balanced Escape Determines Resolution of Dynamic Founder Virus Escape Processes in HIV-1 Infection.

Justine E Sunshine, Brendan B Larsen, Brandon Maust, Ellie Casey, Wenje Deng, Lennie Chen, Dylan H Westfall, Moon Kim, Hong Zhao, Suvankar Ghorai and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 29 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Justine E SunshineVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Brendan B LarsenDepartment of Microbiology, University of Washington, Seattle, Washington, USA.
Brandon MaustDepartment of Microbiology, University of Washington, Seattle, Washington, USA.
Ellie CaseyDepartment of Microbiology, University of Washington, Seattle, Washington, USA.
Wenje DengDepartment of Microbiology, University of Washington, Seattle, Washington, USA.
Lennie ChenDepartment of Microbiology, University of Washington, Seattle, Washington, USA.
Dylan H WestfallDepartment of Microbiology, University of Washington, Seattle, Washington, USA.
Moon KimDepartment of Microbiology, University of Washington, Seattle, Washington, USA.
Hong ZhaoDepartment of Microbiology, University of Washington, Seattle, Washington, USA.
Suvankar GhoraiDepartment of Microbiology, University of Washington, Seattle, Washington, USA.
Erinn Lanxon-CooksonDepartment of Microbiology, University of Washington, Seattle, Washington, USA.
Morgane RollandU.S. Military HIV Research Program, Silver Spring, Maryland, USA, and The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, USA.
Ann C CollierDepartment of Medicine, University of Washington, Seattle, Washington, USA.
Janine MaenzaDepartment of Medicine, University of Washington, Seattle, Washington, USA.
James I MullinsDepartment of Microbiology, University of Washington, Seattle, Washington, USA Department of Medicine, University of Washington, Seattle, Washington, USA Department of Laboratory Medicine, University of Washington, Seattle, Washington, USA.
Nicole FrahmVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA Department of Global Health, University of Washington, Seattle, Washington, USA nfrahm@fredhutch.org.
University of Washington · USFred Hutch Cancer Center · USHenry M. Jackson Foundation · US

Funding

Washington National Primate Research CenterP51OD010425 · OD · UNIVERSITY OF WASHINGTON · PI Mari Ostendorf · 2012 to 2026
$201.8M
University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI Kenneth Sherr · 1988 to 2026
$104.9M
Viral Determinants of HIV-1 Transmission in African HeterosexualsP01AI057005 · NIAID · UNIVERSITY OF WASHINGTON · PI COREY, LAWRENCE · 2003 to 2014
$20.5M
VENEREAL DISEASET32AI007140 · NIAID · UNIVERSITY OF WASHINGTON · PI Julia Cook Dombrowski · 1985 to 2026
$19.4M
Mechanisms of Formation and Persistence of Active HIV ReservoirsR01AI111806 · NIAID · UNIVERSITY OF WASHINGTON · PI MULLINS, JAMES IVAN · 2014 to 2018
$4.3M
Role of proviral loci in HIV latencyR01AI125026 · NIAID · UNIVERSITY OF WASHINGTON · PI MULLINS, JAMES IVAN · 2016 to 2019
$3.4M
Low-frequency HIV-1 Drug Resistance in Primary HIV-1 InfectionR01AI078802 · NIAID · UNIVERSITY OF WASHINGTON · PI STEKLER, JOANNE DONNA · 2009 to 2012
$1.7M
NIAID NIH HHS P01 AI057005NIAID NIH HHS P01AI057005NIAID NIH HHS P30 AI027757NIAID NIH HHS P30AI027757NIAID NIH HHS R01 AI078802NIAID NIH HHS R01 AI111806NIAID NIH HHS R01 AI125026NIAID NIH HHS T32 AI007140NIAID NIH HHS T32AI007140NIH HHS P51 OD010425
6 · The paper itself

Abstract

unlabelledTo understand the interplay between host cytotoxic T-lymphocyte (CTL) responses and the mechanisms by which HIV-1 evades them, we studied viral evolutionary patterns associated with host CTL responses in six linked transmission pairs. HIV-1 sequences corresponding to full-length p17 and p24 gag were generated by 454 pyrosequencing for all pairs near the time of transmission, and seroconverting partners were followed for a median of 847 days postinfection. T-cell responses were screened by gamma interferon/interleukin-2 (IFN-γ/IL-2) FluoroSpot using autologous peptide sets reflecting any Gag variant present in at least 5% of sequence reads in the individual's viral population. While we found little evidence for the occurrence of CTL reversions, CTL escape processes were found to be highly dynamic, with multiple epitope variants emerging simultaneously. We found a correlation between epitope entropy and the number of epitope variants per response (r = 0.43; P = 0.05). In cases in which multiple escape mutations developed within a targeted epitope, a variant with no fitness cost became fixed in the viral population. When multiple mutations within an epitope achieved fitness-balanced escape, these escape mutants were each maintained in the viral population. Additional mutations found to confer escape but undetected in viral populations incurred high fitness costs, suggesting that functional constraints limit the available sites tolerable to escape mutations. These results further our understanding of the impact of CTL escape and reversion from the founder virus in HIV infection and contribute to the identification of immunogenic Gag regions most vulnerable to a targeted T-cell attack. IMPORTANCE: Rapid diversification of the viral population is a hallmark of HIV-1 infection, and understanding the selective forces driving the emergence of viral variants can provide critical insight into the interplay between host immune responses and viral evolution. We used deep sequencing to comprehensively follow viral evolution over time in six linked HIV transmission pairs. We then mapped T-cell responses to explore if mutations arose due to adaption to the host and found that escape processes were often highly dynamic, with multiple mutations arising within targeted epitopes. When we explored the impact of these mutations on replicative capacity, we found that dynamic escape processes only resolve with the selection of mutations that conferred escape with no fitness cost to the virus. These results provide further understanding of the complicated viral-host interactions that occur during early HIV-1 infection and may help inform the design of future vaccine immunogens.

Indexed as

Genetic FitnessAmino Acid SequenceBase SequenceEntropyEpitopes, T-LymphocyteFounder Effectgag Gene Products, Human Immunodeficiency VirusHigh-Throughput Nucleotide SequencingHIV-1HIV SeropositivityHumansImmune EvasionInterferon-gammaInterleukin-2Molecular Sequence DataMutationEpitopes, T-Lymphocytegag Gene Products, Human Immunodeficiency VirusInterferon-gammaInterleukin-2

Identifiers

PMID26223634
PMCPMC4580195
OpenAlexW1961845878

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.